Ross Reynolds interviews Carolyn Anderman, director of international programs for One By One, a Seattle-based group helping women in Africa recover from a devastating birth complication called obstetric fistula. Affected women are often shunned in their communities for a condition that can be fixed with a $500 operation.
One day in the summer of 2013, 25-year-old Seteng Horo found herself on a bus to the nearest public hospital, about four hours away from her remote village in the eastern Indian state of Jharkhand. It's not a trip she can afford to take often — buses are infrequent, the journey is long and the cost of about a dollar roundtrip is not insignificant. But she had no choice. She was running a temperature and had been bleeding for days. The reason: an unsafe abortion performed by a village midwife.
Marcie Sillman speaks with Patricia Coffey and Maggie Kilbourne-Brook, both of the Seattle-based global health nonprofit PATH, about the Caya countoured diaphragm, also known as the SILCS diaphragm, which was recently approved by the FDA.
NPR's Jason Beaubien is in Kailahun, Sierra Leone, covering the Ebola outbreak that began in March in Guinea and has spread to neighboring countries. This morning, he talked with us about a controversial burial, the impact of the "no touching" recommendation — and a sign of hope.
David Hyde talks with Mitchell Warren about the breakthroughs and challenges of HIV prevention over the last 30 years. Warren is the executive director of AVAC, an international non-governmental organization that works on HIV prevention.
Warren said that one of the greatest breakthroughs in HIV-AIDS prevention was the rise of the citizen activism that pushed for funding, creativity and urgency in research. "AIDS really changed how research happened," he said. "Science changed because communities ‘acted up.’"
Wiping out malaria is a top goal for many leaders in global health.
Fewer people are dying now from the mosquito-borne disease than at any other time in history. "And there's a very, very strong belief now that malaria can be eliminated," says Joy Phumaphi, who chairs the African Leaders Malaria Alliance.
But when you look at the overall numbers on malaria, eradication almost seems like a pipe dream.
Susan Desmond-Hellmann, the chancellor of the University of California, San Francisco, will be next chief executive officer of the Bill and Melinda Gates Foundation, one of the largest philanthropic organizations in the world with a $40 billion endowment.
The AP reports that the foundation has been looking for a CEO since Jeff Raikes announced his retirement in September.
Ross Reynolds talks with Dr. Kathy Neuzil about a vaccine for the deadly brain disease Japanese encephalitis that has been recently approved by the World Health Organization. Neuzil is a professor in the University of Washington's Department of Global Health and the director of the Vaccine Access and Delivery Program at Seattle's PATH, where the vaccine was tested.
In the global fight against HIV/AIDS, there's some very good news. According to a new report from the United Nations, the number of new HIV infections are down by nearly one-third over the last decade. Among children new infections are down 52 percent. The number of AIDS-related deaths are also down.
Nyaope is a whitish powder - low-grade heroin mixed with ingredients such as rat poison and sometimes even crushed-up medicine for people with HIV. Sprinkled on top of marijuana, it is a highly addictive, life-wrecking cocktail.
Why didn’t the TARP bailout fund help the small businesses and homeowners who were slammed by the 2008 financial crash? Neil Barofsky left his job at the US Attorney’s Office in New York to become special inspector general in charge of overseeing the bailout money. He says, from his first days on the job he was met with hostility from the treasury officials overseeing the TARP fund. He charges that Treasury Secretary Timothy Geithner funneled money to Wall Street firms in ways that bordered on corruption. Neil Barofsky joins us with the inside story.
Access to HIV and TB treatment has been improving worldwide. The rate of new infections is going down. But tuberculosis remains deadly, especially for the poverty stricken — TB killed 1.4 million people in 2011. Luwiza Makukula was diagnosed with HIV and TB after her husband died in 2001. Not only was she sick, she was completely isolated. Today, she works with NGOs focused on treatment, care, and support for HIV/TB patients, including Zambia's Community Initiative for TB, HIV/AIDS and Malaria (CITAM+). Luwiza Makukula joins us.